The drug is active against Human Endogenous Retroviruses (HERVs) and possibly Epstein–Barr virus, which have been suggested in the pathogenesis of relapsing-remitting MS.
This medication is effective against Human Endogenous Retroviruses (HERVs) and potentially Epstein–Barr virus, both of which are thought to play a role in the development of relapsing-remitting multiple sclerosis.